Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Oct 24, 2026 | Humana | Rapid Whole Genome Sequencing (rWGS) of Critically Ill InfantsPayerPolicy · HUMANA-RAPID-WHOLE-GENOME-SEQUENCING-RWGS-OF-CRITICALLY-ILL-INFANTS-LA-MEDICAID | Metadata changed |
|---|
| Oct 24, 2026 | Humana | Molecular Diagnostic Assays and Breath Testing for Transplant RejectionPayerPolicy · HUMANA-MOLECULAR-DIAGNOSTIC-ASSAYS-AND-BREATH-TESTING-FOR-TRANSPLANT-REJECTION-LA-MEDICAID | Metadata changed |
|---|
| Oct 24, 2026 | Humana | Mental Health Intensive Outpatient Services In Lieu of ServicePayerPolicy · HUMANA-MENTAL-HEALTH-INTENSIVE-OUTPATIENT-SERVICES-IN-LIEU-OF-SERVICE-LA-MEDICAID | New policy |
|---|
| Oct 24, 2026 | Humana | Home HealthPayerPolicy · HUMANA-HOME-HEALTH-LA-MEDICAID | Metadata changed |
|---|
| Oct 24, 2026 | Humana | Applied Behavior AnalysisPayerPolicy · HUMANA-APPLIED-BEHAVIOR-ANALYSIS-LA-MEDICAID | New policy |
|---|
| Oct 24, 2026 | Humana | 23-Hour Behavioral Health Observation - In Lieu of ServicePayerPolicy · HUMANA-23-HOUR-BEHAVIORAL-HEALTH-OBSERVATION-IN-LIEU-OF-SERVICE-LA-MEDICAID | Metadata changed |
|---|
| Oct 24, 2026 | Humana | Single Gene and Molecular Biomarker Testing for Solid TumorsPayerPolicy · HUMANA-SINGLE-GENE-AND-MOLECULAR-BIOMARKER-TESTING-FOR-SOLID-TUMORS-MA | Metadata changed |
|---|
| Oct 24, 2026 | Humana | Genetic and Coagulation Testing for Noncancer Blood DisordersPayerPolicy · HUMANA-GENETIC-AND-COAGULATION-TESTING-FOR-NONCANCER-BLOOD-DISORDERS-MA | Metadata changed |
|---|
| Oct 24, 2026 | Humana | Genetic Testing for Hereditary CancerPayerPolicy · HUMANA-GENETIC-TESTING-FOR-HEREDITARY-CANCER-MA | Metadata changed |
|---|
| Oct 24, 2026 | Humana | Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate CancerPayerPolicy · HUMANA-GENETIC-TESTING-FOR-HEREDITARY-BREAST-OVARIAN-PANCREATIC-AND-PROSTATE-CANCER-MA | Metadata changed |
|---|
| Oct 24, 2026 | Humana | Genetic Testing for Hematologic Malignancies and Suspected Myeloid DisordersPayerPolicy · HUMANA-GENETIC-TESTING-FOR-HEMATOLOGIC-MALIGNANCIES-AND-SUSPECTED-MYELOID-DISORDERS-MA | Metadata changed |
|---|
| Oct 24, 2026 | Humana | Gene Expression Profiling for Cancer IndicationsPayerPolicy · HUMANA-GENE-EXPRESSION-PROFILING-FOR-CANCER-INDICATIONS-MA | Metadata changed |
|---|
| Oct 24, 2026 | Humana | Comprehensive Genomic Profiling and Multigene Panel Testing for Solid TumorsPayerPolicy · HUMANA-COMPREHENSIVE-GENOMIC-PROFILING-AND-MULTIGENE-PANEL-TESTING-FOR-SOLID-TUMORS-MA | Metadata changed |
|---|
| Oct 24, 2026 | Humana | OrthoticsPayerPolicy · HUMANA-ORTHOTICS-VA-MEDICAID | Metadata changed |
|---|
| Oct 24, 2026 | Humana | OrthoticsPayerPolicy · HUMANA-ORTHOTICS-KY-MEDICAID | Metadata changed |
|---|
| Oct 24, 2026 | Humana | Genomic and Molecular Biomarker Testing for CancerPayerPolicy · HUMANA-GENOMIC-AND-MOLECULAR-BIOMARKER-TESTING-FOR-CANCER-VA-MEDICAID | Metadata changed |
|---|
| Oct 24, 2026 | Humana | Genomic and Molecular Biomarker Testing for CancerPayerPolicy · HUMANA-GENOMIC-AND-MOLECULAR-BIOMARKER-TESTING-FOR-CANCER-KY-MEDICAID | New policy |
|---|
| Oct 24, 2026 | Humana | Gene Expression Profiling for Cancer IndicationsPayerPolicy · HUMANA-GENE-EXPRESSION-PROFILING-FOR-CANCER-INDICATIONS-VA-MEDICAID | Metadata changed |
|---|
| Oct 24, 2026 | Humana | Genomic and Molecular Biomarker Testing for CancerPayerPolicy · HUMANA-GENOMIC-AND-MOLECULAR-BIOMARKER-TESTING-FOR-CANCER-FL-MEDICAID | Metadata changed |
|---|
| Oct 24, 2026 | Humana | Gene Expression Profiling for Cancer IndicationsPayerPolicy · HUMANA-GENE-EXPRESSION-PROFILING-FOR-CANCER-INDICATIONS-FL-MEDICAID | Metadata changed |
|---|
| Oct 24, 2026 | Humana | Neuroablative Techniques for Chronic PainPayerPolicy · HUMANA-NEUROABLATIVE-TECHNIQUES-FOR-CHRONIC-PAIN-MA-FUTURE | New policy |
|---|
| Oct 24, 2026 | Humana | Injections for Pain ConditionsPayerPolicy · HUMANA-INJECTIONS-FOR-PAIN-CONDITIONS-MA-FUTURE | New policy |
|---|
| Oct 24, 2026 | Point32Health | Targeted Immunomodulators Self-administrationPayerPolicy · POINT32HEALTH-PMNG-21031 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Ranolazine Extended-Release TabletPayerPolicy · POINT32HEALTH-PMNG-17861 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Pegfilgrastim ProductsPayerPolicy · POINT32HEALTH-PMNG-17381 | Retired |
|---|
| Oct 24, 2026 | Point32Health | HIV Pre-Exposure Prophylaxis (PrEP) MedicationsPayerPolicy · POINT32HEALTH-PMNG-15281 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Removal of Benign Skin LesionsPayerPolicy · POINT32HEALTH-MNG-19491 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Percutaneous Tibial Nerve Stimulation (PTNS)PayerPolicy · POINT32HEALTH-MNG-19731 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Long-Term Services & Supports (LTSS) for Tufts Health One CarePayerPolicy · POINT32HEALTH-MNG-24146 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Home Health Care Services for Tufts Health Together, Tufts Health RITogether, and Tufts Health One CarePayerPolicy · POINT32HEALTH-MNG-20261 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Behavioral Health Level of Care for Non- 24 Hour/Intermediate/Diversionary ServicesPayerPolicy · POINT32HEALTH-MNG-18951 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Behavioral Health Inpatient and 24 Hour Level of Care DeterminationsPayerPolicy · POINT32HEALTH-MNG-18941 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Targeted Immunomodulators Skilled AdministrationPayerPolicy · POINT32HEALTH-MDMNG-21041 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Synagis (palivizumab)PayerPolicy · POINT32HEALTH-MDMNG-13926 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Respiratory InterleukinsPayerPolicy · POINT32HEALTH-MDMNG-27711 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Medical Benefit Step TherapyPayerPolicy · POINT32HEALTH-MDMNG-24926 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Imaavy (nipocalimab)PayerPolicy · POINT32HEALTH-MDMNG-25201 | Retired |
|---|
| Oct 24, 2026 | Point32Health | HIV Pre-Exposure Prophylaxis (PrEP) MedicationsPayerPolicy · POINT32HEALTH-MDMNG-12401 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Epioxa (riboflavin 5’-phosphate ophthalmic solution)PayerPolicy · POINT32HEALTH-MDMNG-28481 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Adstiladrin (nadofaragene firadenovec-vncg)PayerPolicy · POINT32HEALTH-MDMNG-12211 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Adstiladrin (nadofaragene firadenovec-vncg)PayerPolicy · POINT32HEALTH-MDMNG-12201 | Retired |
|---|
| Oct 24, 2026 | Point32Health | Xerese (acyclovir and hydrocortisone)PayerPolicy · POINT32HEALTH-PMNG-29181 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Sofosbuvir/velpatasvirPayerPolicy · POINT32HEALTH-PMNG-29171 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Sodium-Glucose Co-Transporter 2 (SGLT2) InhibitorsPayerPolicy · POINT32HEALTH-PMNG-29161 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Sodium-Glucose Co-Transporter 2 (SGLT2) InhibitorsPayerPolicy · POINT32HEALTH-PMNG-28981 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Rifamycin ProductsPayerPolicy · POINT32HEALTH-PMNG-18001 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Proton Pump Inhibitors (PPIs)PayerPolicy · POINT32HEALTH-PMNG-26191 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Pharmacy Products Without Specific CriteriaPayerPolicy · POINT32HEALTH-PMNG-17461 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Mavyret (glecaprevir/pibrentasvir)PayerPolicy · POINT32HEALTH-PMNG-29151 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Ledipasvir/sofosbuvirPayerPolicy · POINT32HEALTH-PMNG-29141 | Metadata changed |
|---|